186 related articles for article (PubMed ID: 6972964)
41. T-cell-derived IgE-binding factors. II. Purification and characterization of IgE-binding factors produced by human T cell leukemia/lymphoma virus-1-transformed T lymphocytes.
Sarfati M; Nutman TB; Suter U; Hofstetter H; Delespesse G
J Immunol; 1987 Dec; 139(12):4055-60. PubMed ID: 2826578
[TBL] [Abstract][Full Text] [Related]
42. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. IV. Delineation of target cells and mechanisms of action of SFA and EFA in inhibiting in vitro induction of FcR epsilon expression.
Marcelletti JF; Katz DH
J Immunol; 1984 Dec; 133(6):2845-51. PubMed ID: 6238087
[TBL] [Abstract][Full Text] [Related]
43. IgE formation in the rat following infection with Nippostrongylus brasiliensis. III. Soluble factor for the generation of IgE-bearing lymphocytes.
Urban JF; Ishizaka T; Ishizaka K
J Immunol; 1977 Aug; 119(2):583-90. PubMed ID: 301898
[TBL] [Abstract][Full Text] [Related]
44. Characterization of human T cell-derived IgE-potentiating factor.
Young M; Geha RS; Maksad KN; Leung DY
Eur J Immunol; 1986 Aug; 16(8):985-91. PubMed ID: 3488913
[TBL] [Abstract][Full Text] [Related]
45. IgE receptor on human lymphocytes. IV. Further analysis of its structure and of the role of N-linked carbohydrates.
Letellier M; Nakajima T; Delespesse G
J Immunol; 1988 Oct; 141(7):2374-81. PubMed ID: 2971725
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the Fc receptors for IgE on human lymphocytes and monocytes.
Melewicz FM; Plummer JM; Spiegelberg HL
J Immunol; 1982 Aug; 129(2):563-9. PubMed ID: 6211489
[TBL] [Abstract][Full Text] [Related]
47. Regulatory role of IgE-binding factors from rat T lymphocytes. V. The carbohydrate moieties in IgE-potentiating factors and IgE-suppressive factors.
Yodoi J; Hirashima M; Ishizaka K
J Immunol; 1982 Jan; 128(1):289-95. PubMed ID: 6459370
[No Abstract] [Full Text] [Related]
48. Recombinant human immune interferon induces increased IgE receptor expression on the human monocyte cell line U-937.
Náray-Fejes-Tóth A; Guyre PM
J Immunol; 1984 Oct; 133(4):1914-9. PubMed ID: 6088628
[TBL] [Abstract][Full Text] [Related]
49. Mast cell Fc epsilonRI expression in the rat intestinal mucosa and tongue is enhanced during Nippostrongylus brasiliensis infection and can be up-regulated by in vivo administration of IgE.
Shaikh N; Rivera J; Hewlett BR; Stead RH; Zhu FG; Marshall JS
J Immunol; 1997 Apr; 158(8):3805-12. PubMed ID: 9103447
[TBL] [Abstract][Full Text] [Related]
50. Isotope-specific T cell factors for the IgE response.
Ishizaka K
Crit Rev Immunol; 1985; 5(3):229-62. PubMed ID: 3156728
[TBL] [Abstract][Full Text] [Related]
51. Lymphocytes bearing Fc receptors for IgE. VII. Possible participation of phospholipase A2 in the glycosylation of IgE-binding factors.
Yodoi J; Hirashima M; Hirata F; DeBlas AL; Ishizaka K
J Immunol; 1981 Aug; 127(2):476-82. PubMed ID: 6972965
[No Abstract] [Full Text] [Related]
52. IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor.
Jardieu P; Uede T; Ishizaka K
J Immunol; 1984 Dec; 133(6):3266-73. PubMed ID: 6208275
[TBL] [Abstract][Full Text] [Related]
53. Relationship among IgE-binding factors with various molecular weights.
Jardieu P; Moore K; Martens C; Ishizaka K
J Immunol; 1985 Oct; 135(4):2727-34. PubMed ID: 3928755
[TBL] [Abstract][Full Text] [Related]
54. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. V. Preliminary physicochemical characterization of the T cell-selective IgE-induced regulant EIRT.
Marcelletti JF; Katz DH
J Immunol; 1986 Oct; 137(8):2599-610. PubMed ID: 3489768
[TBL] [Abstract][Full Text] [Related]
55. In vivo kinetics and nature of rat IgE-bearing lymphocytes after IgE stimulation.
Manouvriez P; Bazin H
J Immunol; 1984 Dec; 133(6):3274-81. PubMed ID: 6238096
[TBL] [Abstract][Full Text] [Related]
56. Biologically active molecules regulating the IgE antibody system: biochemical and biological comparisons of suppressive factor of allergy (SFA) and enhancing factor of allergy (EFA).
Katz DH; Chen SS; Liu FT; Bogowitz CA; Katz LR
J Mol Cell Immunol; 1984; 1(3):157-66. PubMed ID: 6242855
[TBL] [Abstract][Full Text] [Related]
57. Formation of IgE binding factors by human T lymphocytes.
Ishizaka K; Sandberg K
J Immunol; 1981 May; 126(5):1692-6. PubMed ID: 6971311
[TBL] [Abstract][Full Text] [Related]
58. Modulation of the biologic activities of IgE binding factor. VI. The activation of phospholipase by glycosylation enhancing factor.
Iwata M; Akasaki M; Ishizaka K
J Immunol; 1984 Sep; 133(3):1505-12. PubMed ID: 6431000
[TBL] [Abstract][Full Text] [Related]
59. Role of IgE receptors in effector function of human eosinophils.
Capron M; Spiegelberg HL; Prin L; Bennich H; Butterworth AE; Pierce RJ; Ouaissi MA; Capron A
J Immunol; 1984 Jan; 132(1):462-8. PubMed ID: 6228581
[TBL] [Abstract][Full Text] [Related]
60. Suppression of IgE synthesis in mouse plasma cells and B cells by rat IgE-suppressive factor.
Uede T; Huff TF; Ishizaka K
J Immunol; 1984 Aug; 133(2):803-8. PubMed ID: 6610711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
